Results 151 to 160 of about 2,333,106 (317)

Comparison of the biological activity of different probiotic strains under aerobic and anaerobic conditions. [PDF]

BMC Microbiol
Guilbaud J, Fadhlaoui K, Chalancon S, Beyssac E, Laine E, Garrait G.   +5 more
europepmc   +1 more source

Predictors of response and rational combinations for the novel MCL‐1 inhibitor MIK665 in acute myeloid leukemia

Molecular Oncology, EarlyView.
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad, Rhiannon Newman, Elmira Khabusheva, Sofia Aakko, Eric Durand, Mahesh Tambe, Heikki Kuusanmäki, Alun Parsons, Juho J. Miettinen, Komal Kumar Javarappa, Ezgi June Olgac, Nemo Ikonen, Mika Kontro, Kimmo Porkka, Heiko Maacke, Janghee Woo, Ensar Halilovic, Caroline A. Heckman   +17 more
wiley   +1 more source

Biological activity of Nothoscordum bivalve (L.) Britton and Parthenium incanum Kunth extracts

, 2018
David Alejandro Hernández-Marín, Fidel Guevara‐Lara, Catalina Rivas-Morales, Jorge Armando Verduzco-Martínez, Sergio Arturo Galindo-Rodríguez, Eduardo Sánchez-García   +5 more
openalex   +1 more source

GC-MS profiling and biological activities of Conamomum vietnamense leaf extracts from Vietnam

Thi Thuy Quynh Tran, Kiep Minh, Duc Phan Nguyen Duong, Tuan Trong Vo, Mong Tham Vo, Ty Viet Pham, Danh Đức Nguyễn, Tran Van Chen   +7 more
openalex   +2 more sources

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

Molecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande, Marcela de Oliveira Silva, Mariana Bisarro dos Reis, Rodrigo de Oliveira Cavagna, Luciane Sussuchi, Icaro Alves Pinto, Natalia Zampieri Pontes, Rodrigo Sampaio Chiarantano, Flavio Augusto Ferreira da Silva, Pedro de Marchi, Letícia Ferro Leal, Rui M. Reis   +11 more
wiley   +1 more source

Multifaceted Biological Activity of Selected Flavone <i>C</i>-Monoglucosides. [PDF]

Int J Mol Sci
Zielińska D, Zieliński H.
europepmc   +1 more source

Design, Synthesis,and Biological Activity Evaluationof Flavonol Derivatives Containing Piperazine and Piperidine Thiourea

Yuhong Wang (85102), Hong Fu (37557), Haotao Pu (19864748), Hongqian Zou (20111801), Han Yang (704814), Xiaoyan Pan (2178640), Xianghui Ruan (4216966), Wei Xue (219900)   +7 more
openalex   +1 more source

Biological Activity of Some Cobalt(II) andMolybdenum(VI) Complexes: in vitro Cytotoxicity [PDF]

, 2004
Nikos Katsaros, Maria E. Katsarou, Sofija P. Sovilj, Ksenija Babić‐Samardžija, Dragana Mitić   +4 more
openalex   +1 more source

BIOLOGICAL ACTIVITIES OF ALBONOURSIN

The Journal of Antibiotics, 1973
K, Fukushima, K, Yazawa, T, Arai
openaire   +3 more sources

Aggressive prostate cancer is associated with pericyte dysfunction

Molecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero, Ane Martinez‐Larrinaga, Joaquim Grego‐Bessa, Saioa Garcia‐Longarte, Hielke van Splunder, Ianire Astobiza, Amaia Ercilla, Laura Bozal‐Basterra, Isabel Mendizabal, Pilar Villacampa, Arkaitz Carracedo, Mariona Graupera   +11 more
wiley   +1 more source